Management of Atrial Fibrillation in Adults: Prevention of Thromboembolism and Symptomatic Treatment

Joseph L. Blackshear; Stephen L. Kopecky; Scott C. Litin; Robert E. Safford; Stephen C. Hammill

doi:10.4065/71.2.150

journal article Feb 01, 1996

Management of Atrial Fibrillation in Adults: Prevention of Thromboembolism and Symptomatic Treatment

Joseph L. Blackshear Stephen L. Kopecky Scott C. Litin Robert E. Safford Stephen C. Hammill

Mayo Clinic Proceedings Vol. 71 No. 2 pp. 150-160 · Elsevier BV

View at Publisher Save 10.4065/71.2.150

Topics

No keywords indexed for this article. Browse by subject →

References

65

[1]

Viko "Clinical report on use of quinidin sulphate" Arch Intern Med (1923) 10.1001/archinte.1923.00110150044003

[2]

National Heart, Lung, and Blood Institute Working Group on Atrial Fibrillation "Atrial fibrillation: current understandings and research imperatives" J Am Coll Cardiol (1993) 10.1016/0735-1097(93)90765-s

[3]

Feinberg "Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications" Arch Intern Med (1995) 10.1001/archinte.1995.00430050045005

[4]

Benjamin "Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart study" JAMA (1994) 10.1001/jama.1994.03510350050036

[5]

Vaziri "Echocardiographic predictors of nonrheumatic atrial fibrillation: the Framingham Heart study" Circulation (1994) 10.1161/01.cir.89.2.724

[6]

Creswell "Hazards of postoperative atrial arrhythmias" Ann Thorac Surg (1993) 10.1016/0003-4975(93)90894-n

[7]

Hart "Atrial fibrillation and stroke: revisiting the dilemmas [editorial]" Stroke (1994) 10.1161/01.str.25.7.1337

[8]

Manning "Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study" J Am Coll Cardiol (1995) 10.1016/0735-1097(94)00560-d

[9]

Stoddard "Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study" J Am Coll Cardiol (1995) 10.1016/0735-1097(94)00396-8

[10]

Wolf "Atrial fibrillation: a major contributor to stroke in the elderly; the Framingham study" Arch Intern Med (1987) 10.1001/archinte.1987.00370090041008

[11]

Wolf "Atrial fibrillation as an independent risk factor for stroke: the Framingham study" Stroke (1991) 10.1161/01.str.22.8.983

[12]

Atrial Fibrillation Investigators "Risk factors for stroke and efficacy of anti-thrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials" Arch Intern Med (1994) 10.1001/archinte.1994.00420130036007

[13]

EAFT (European Atrial Fibrillation Trial) Study Group "Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke" Lancet (1993) 10.1016/0140-6736(93)92358-z

[14]

Stroke Prevention in Atrial Fibrillation Investigators "Predictors of thromboembolism in atrial fibrillation. II. Echocardiographic features of patients at risk" Ann Intern Med (1992) 10.7326/0003-4819-116-1-6

[15]

Taylor "Usefulness of atrial fibrillation as a predictor of stroke after isolated coronary artery bypass grafting" Am J Cardiol (1987) 10.1016/0002-9149(87)91045-9

[16]

Hashimoto "Influence of clinical and hemodynamic variables on risk of supraventricular tachycardia after coronary artery bypass" J Thorac Cardiovasc Surg (1991) 10.1016/s0022-5223(19)36793-5

[17]

Arnold "Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter" J Am Coll Cardiol (1992) 10.1016/0735-1097(92)90530-z

[18]

Stroke Prevention in Atrial Fibrillation Investigators "Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study" Lancet (1994)

[19]

Stroke Prevention in Atrial Fibrillation Investigators "Stroke Prevention in Atrial Fibrillation Study: final results" Circulation (1991) 10.1161/01.cir.84.2.527

[20]

Petersen "Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAK study" Lancet (1989) 10.1016/s0140-6736(89)91200-2

[21]

Albers "Atrial fibrillation and stroke: three new studies, three remaining questions" Arch Intern Med (1994) 10.1001/archinte.1994.00420130030006

[22]

Stroke Prevention in Atrial Fibrillation Investigators "Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: the Stroke Prevention in Atrial Fibrillation Study" J Stroke Cerebrovasc Dis (1995) 10.1016/s1052-3057(10)80166-1

[23]

Connolly "Canadian Atrial Fibrillation Anticoagulation (CAFA) Study" J Am Coll Cardiol (1991) 10.1016/0735-1097(91)90585-w

[24]

Ezekowitz "Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation" N Engl J Med (1992) 10.1056/nejm199211123272002

[25]

Gottlieb "Anticoagulation in atrial fibrillation: does efficacy in clinical trials translate into effectiveness in practice?" Arch Intern Med (1994) 10.1001/archinte.1994.00420170093009

[26]

Hylek "Risk factors for intracranial hemorrhage in outpatients taking warfarin" Ann Intern Med (1994) 10.7326/0003-4819-120-11-199406010-00001

[27]

Andrews "Complications of warfarin therapy monitored by the International Normalized Ratio versus the prothrombin time ratio" Clin Cardiol (1995) 10.1002/clc.4960180208

[28]

Laupacis "Antithrombotic therapy in atrial fibrillation" Chest (1995) 10.1378/chest.108.4_supplement.352s

[29]

Becker "Antithrombotic therapy: an abbreviated reference for clinicians" Arch Intern Med (1995) 10.1001/archinte.1995.00430020034005

[30]

Stein "Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves" Chest (1992) 10.1378/chest.102.4_supplement.445s

[31]

Pritchett "Management of atrial fibrillation" N Engl J Med (1992) 10.1056/nejm199205073261906

[32]

Falk "Control of the ventricular rate in atrial fibrillation" (1992)

[33]

Grogan "Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy" Am J Cardiol (1992) 10.1016/0002-9149(92)90705-4

[34]

Williamson "Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation" N Engl J Med (1994) 10.1056/nejm199410063311404

[35]

Black "Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation: a multicenter study" Circulation (1994) 10.1161/01.cir.89.6.2509

[36]

Fatkin "Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for “atrial stunning” as a mechanism of thromboembolic complications" J Am Coll Cardiol (1994) 10.1016/0735-1097(94)90412-x

[37]

Manning "Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation" J Am Coll Cardiol (1994) 10.1016/0735-1097(94)90652-1

[38]

Grimm "Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography" J Am Coll Cardiol (1993) 10.1016/0735-1097(93)90543-a

[39]

Pagadala "Thromboembolic risk of chronic atrial flutter: is the risk underestimated? [abstract]" Circulation (1994)

[40]

Wood "Surprisingly high frequency of thromboembolism in chronic atrial flutter [abstract]" PACE (1995)

[41]

Schnittger "Value of transoesophageal echocardiography before DC cardioversion in patients with atrial fibrillation: assessment of embolic risk" Br Heart J (1995) 10.1136/hrt.73.4.306

[42]

Wellens "Antiarrhythmic drug treatment: need for continuous vigilance" Br Heart J (1992) 10.1136/hrt.67.1.25

[43]

Benjamin "Impact of atrial fibrillation on the risk of death: the Framingham study [abstract]" J Am Coll Cardiol (1995) 10.1016/0735-1097(95)92416-3

[44]

Middlekauff "Antiarrhythmic prophylaxis vs warfarin anticoagulation to prevent thromboembolic events among patients with atrial fibrillation: a decision analysis" Arch Intern Med (1995) 10.1001/archinte.1995.00430090044006

[45]

Coplen "Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta-analysis of randomized control trials" Circulation (1990) 10.1161/01.cir.82.4.1106

[46]

Flaker "Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation" J Am Coll Cardiol (1992) 10.1016/0735-1097(92)90003-6

[47]

Page "Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia" Circulation (1994) 10.1161/01.cir.89.1.224

[48]

Capucci "Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide" Am J Cardiol (1994) 10.1016/0002-9149(94)90915-6

[49]

Podrid "Oral antiarrhythmic drugs used for atrial fibrillation: clinical pharmacology" (1992)

[50]

Naccarelli "Prospective comparison of flecainide versus quinidine in the treatment of paroxysmal atrial fibrillation [abstract]" PACE (1995)

Showing 50 of 65 references

Cited By

49

Worldwide Epidemiology of Atrial Fibrillation

Sumeet S. Chugh, Rasmus Havmoeller · 2014

Circulation

Metrics

49

Citations

65

References

Details

Published: Feb 01, 1996
Vol/Issue: 71(2)
Pages: 150-160
License: View

Authors

Mayo Clinic, Rochester, MN

Cite This Article

Joseph L. Blackshear, Stephen L. Kopecky, Scott C. Litin, et al. (1996). Management of Atrial Fibrillation in Adults: Prevention of Thromboembolism and Symptomatic Treatment. Mayo Clinic Proceedings, 71(2), 150-160. https://doi.org/10.4065/71.2.150

Management of Atrial Fibrillation in Adults: Prevention of Thromboembolism and Symptomatic Treatment

You May Also Like